Showing results (151-160 of 619) with videos related to
Sort By:
Pageof 62
Human Immunology|August 6, 2013
Vaccination against Streptococcus pneumoniae does not induce antibodies against HLA or MICA in clinically stable kidney transplant recipientsMonika Lindemann, Falko M Heinemann, Peter A Horn, et al.Transplantation|June 1, 2012
Long-term response to vaccination against pneumococcal antigens in kidney transplant recipientsMonika Lindemann, Falko M Heinemann, Peter A Horn, et al.Tissue Antigens|April 28, 2005
Peptide-binding characteristics of the novel allele DRB1*0112 are probably identical to DRB1*0101P A Horn, D S DeLuca, K Mueller, et al.Acta Biologica Et Medica Germanica|January 1, 1976
Substrate-stat: a method for characterization of enzymes in concentrated solutions at low substrate concentrationsA Horn, I Clark, R Bublitz, et al.Acta Chirurgica Scandinavica|January 1, 1984
Follow-up of patients with large bowel cancer: a critical evaluationA B Guttormsen, J C Holm, A Horn, et al.Human Gene Therapy|May 1, 1995
Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trialsN A Horn, J A Meek, G Budahazi, et al.Human Immunology|May 13, 2006
The replacement mutation in HLA-DRB1*1211 affects a likely keystone positionPeter A Horn, David S DeLuca, Pavel Jindra, et al.Current Opinion in Microbiology|December 9, 2023
Specialized biopolymers: versatile tools for microbial resilienceJana K Schniete, Thomas Brüser, Marcus A Horn, et al.Cell Cycle (Georgetown, Tex.)|January 29, 2016
Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cellsStefan Radtke, André Görgens, Bing Liu, et al.Neurological Research and Practice|November 22, 2021
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosisMosche Pompsch, Neslinur Fisenkci, Peter A Horn, et al.Pageof 62